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     An injection or injections of an androgen resulted in several fold increase of the hemopoietic 
  spleen colonies in 600 R irradiated mice. As one of the mechanisms explaining this phenomenon 
 radiosensitivity of the hemopoietic stem cells in androgen injected mice was studied by irradiating 
 the cells in vivo and in vitro with 300 R. Approximately 3 fold, at maximum, resistence to 
  radiation was demonstrated. The mice injected with an androgen before and after 400 R 
  irradiation showed an earlier recovery of the leucocyte and granulocyte counts than the control. 
   Androgens have been known to stimulate erythropoiesis. Reports on their effect, 
however, on the pluripotent hemopoietic stem cell (CFU-S or CFU) and the granulocyte 
progenitor cells (CFU-C or CFC) are not many. The present communication is to report 
our preliminary studies on this subject. 
                     MATERIALAND METHOD 
   Female DS mice, 10 to 14 weeks old, supplied from Shionogi Pharmaceutical 
Company were used. Nandrolone decanoate (NAN-D) was used as an androgen. NAN-D 
has the strongest, per weight basis, erythropoietic activity among commercially available 
parenteral androgens 1) Exogenous spleen colony method of Till and McCulloch2) was 
used to estimate the number of transplantable CFU. Endogenous spleen colony method 
of Marsh et a1.3' was used to study the effect of an androgen on endogenous CFU. A 
compact "Co irradiation facility of The Institute for Chemical Research of Kyoto Univer-
sity was used to irradiate mice or bone marrow and spleen suspensions.'" Polycythemic 
mice were made by intraperitoneal transfusions of 0.45 to 0. 5 ml of packed RBC per 
day on two successive days. Only mice whose hematocrit above 55% at the time of 
sacrifice or whose reticulocyte count less than 0. 1% before irradiation in the experiments 
of leucocyte recovery were used. In vitro irradiation of bone marrow and spleen cells 
was performed by irradiating bone marrow and spleen suspensions in Tyrode solution 
with 300 R. Following this, their aliquots (25X 105 and 15X 106 per mouse with bone 
marrow cells and spleen cells, respectively) were injected into 800 R irradiated syngeneic 
mice. Seven to eight days later the mice were sacrificed, the spleens were removed and 
fixed in Bouin's solution, and the surface colonies were counted. In vivo irradiation of 
bone marrow and spleen was performed by irradiating mice with 300 R, the femurs and 
spleens were removed within a few hours after irradiation, and the aliquots of their 
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suspensions were injected into 800 R irradiated syngeneic mice. Subsequent procedures 
were the same as in vitro irradiation. 
                          RESULTS 
1) Effect of NAN-D on the  Hematopoietic Spleen Colony Formation in Irradiated 
Mice 
   Each of experimental mice was injected subcutaneously with NAN-D once or twice 
(once a day for two successive days) and 1 to 7 days after the last injection the animals 
were irradiated with 600 to 640 R of "Co gamma-rays. The mice injected with 2.5 mg 
of NAN-D 5 to 2 days before irradiation significantly increased the number of en-
dogenous.spleen colonies, the maximum increase being more than 7 fold (Table I). In 
subsequent ^ studies NAN-D was injected between 2 and 3 days before irradiation unless 
specified: 
       Table I. Effect of Androgen on Hematopoietic Spleen Colonies in Irradiated Mice 
600 R 
I + 
------------------------------22 Colony count (No. of mice) Ratio to control -8 -6 -2 0 8 
± S. D.                              days 
.l 1 I 11.6 ± 3.3 (10) 7.3* 
i I10.7 ± 3.5 (10) 6.7* 
J, 1I5.6 ~ 3.7 (10) 3.5 * 
i iI1.7 ± 1.1 (10) 1.1 
J, I3.0 ± 2.5 (7) 1.9 
J, I 11.2±6.1( 6) 7.0* 
1 I9.4 ± 4.4( 8) 5.9* 
1.9 1--- 2.0 (7) 1.2 
1.6 + 1.4 (9) 
NAN-D2.5mg 
*; `significant 
2), Effect of NAN-D on the Radiosensitivity of CFU Cells 
As'' one 'of possible mechanisms of this increase of spleen colonies in NAN-D injected 
and irradiated mice, radiosensitivity of CFU cells was tested. 
     Table II, Sensitivity of CFU-S in Androgen-injected Mice to 300R in vitro Irradiation 
    Group ` CellsRatio survived (%) Ratio to control 
NAN-DBone marrow 2. 52 ± 0. 32 (S. D.) 2. 19* 
           Spleen2.46 ± 0.621.48* 
HT -I NAN-DBone marrow 3.38 + 0.562.91* 
           Spleen3.06 + 0.561.84* 
   Sesame oilBone marrow 1.16 + 0.26 
               Spleen1.66 + 0.48
HT :'Hypertransfusion 
      * : significant 
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     Table III. Sensitivity of CFU-S in Androgen-injectedMice to 300R in vivo Irradiation 
   GroupCellsRatio survived (%)Ratio to control 
  NAN-DBone marrow 1.77 f 0.92 (S. D.)1.27 
           Spleen1.72 f 0.221.67*
  Sesame oilBone marrow 1.39 ± 0.31 
  (control)Spleen1.02 ± 0.50"" 
* : significant 
a) In vitro irradiation. The results is shown in Table II. CFU cells in both bone 
marrow and spleen of NAN-D injected mice, whether hypertransfused or not, showed 
a significantly less sensitivity. 
b) In vivo irradiation. In vivo irradiation checks not only radioprotective effect upon 
the cell itself but also effect on the environment which leads to cellular protection. 
The result is shown in Table III. In the NAN-D injected mice, significantly more 
CFU cells in the spleen survived whereas those in the bone marrow did not. 
3) Recovery of Leukocyte after Irradiation 
   Changes of leukocyte, granulocyte and lymphocyte counts after 410 R irradiation is 
shown in Figs. 1 & 2, which shows . an earlier recovery of leukocyte and granulocyte 
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                Fig. 4. Effect of Androgen on Recovery of Granulocytes and 
                  Lymphocytes (II) 
counts in mice given NAN-D after irradiation irrespective of whether they are hyper-
transfused or not. Injections of NAN-D 7 and .6 days before irradiation did not give 
beneficial effect on the recovery of leucocyte count. However, as shown in Figs. 3 & 
4, injections- 3 & 2 days before irradiation resulted in earlier leucocyte and granulocyte 
recovery as in the case of injections immediately after irradiation. 
                         DISCUSSION 
   The increase of endogenous spleen colonies in NAN-D injected and irradiated mice 
is by no means specific. Boggs, Marsh and their group reported a similar effect following 
injections of foreign plasma, phytohemagglutinin, vaccines, sheep red cells and various 
erythropoietic stimuli such as erythropoietin, testosterone or testosterone plus cobalt'," 
They also studied the mechanism of the increase of endogenous spleen colonies in plasma 
injected and irradiated mice." Experiments designed to support or deny various hypoth-
eses were negative except for an increase in the total body pool of colony forming cells. 
The hypothesis that plasma injection increased the fraction of CFU cells which survive 
a given dose of irradiation as compared to untreated cells was negative. In the present 
study, CFU cells in the mice given NAN-D before irradiation is more resistent to radia-
tion than the control, which may explain at least part of the increase in number of 
endogenous spleen colonies after irradiation. In in vivo irradiation, femoral marrow was 
found not to have more number of transplantable CFU cells remaining after irradiation 
than the control. This does not necessarily show bone marrow CFU cells remaining 
after irradiation were not increased, because CFU cells might have moved from the 
bone marrow to the spleen during the time after irradiation and removal of bone 
marrow for CFU assay. The hemopoietic stem cells have been known mostly in the Go 
and enter the S phase after an androgen administration." Murine bone marrow cells in 
the S phase were shown to become radioresistent as much as 10 fold.°1 However, radio-
resistence cannot explain whole increase of endogenous spleen colonies, because in our 
study less than 3 fold radioresistency was obtained. The kinetics of the stem cell system 
appear complex, and as stated by Boggs et al.71 it would be hazardous to draw any con-
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clusions concerning the effect of any given stimulus upon the compartment unless studies 
include more than one type of CFU assay. 
   The mechanism of earlier recovery of granulocyte count after 400 R irradiation in 
the mice given NAN-D may be : 1) less damage of the stem cells, 2) earlier recovery 
of the stem cells, 3) earlier recruitment of CFC to granulocytes by enhanced production 
of colony stimulating factor (CSF), and 4) shift of granulocytes from the marginal to 
the circulating pool. All of the four may not be mutually exclusive. Radiosensitivity of 
the stem cells in mice injected with androgens has been described. Increase of CSF 
production was shown in mice injected with androgens.1) Further studies are needed 
to clarify the mechanism(s) of this earlier recovery of granulocyte count. 
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